​​​​​​​​Publications


  • Shaheed SU, Tait C, Kyriacou K, Linforth R, Salhab M, Sutton C Evaluation of nipple aspirate fluid as a diagnostic tool for early detection of breast cancer. Clin Proteomics. 2018 Jan 11;15:3. doi: 10.1186/s12014-017-9179-4. eCollection 2018.


  • Shaheed SU, Tait C, Kyriacou K, Mullarkey J, Burrill W, Patterson LH, Linforth R, Salhab M, Sutton CW. Nipple aspirate fluid-A liquid biopsy for diagnosing breast health. Proteomics Clin Appl. 2017 May 10. doi: 10.1002/prca.201700015.


  • Hignett S, Tait C, Rigby K, Carder P, Linforth R, Salhab M. Does micro-invasion with DCIS on core biopsy from breast patients indicate whether sentinel lymph node biopsy (SLNB) should be performed? EJSO, 2015, 41, 6, S35


  • Hogan B, Chan S, Salhab M, Linforth R, Tait C. Reducing margin width following breast conserving surgery increases risk of residual disease in the breast.  DOI: http://dx.doi.org/10.1016/j.ejso.2014.08.181


  • Salhab M, Elghazawy R, Tait C, Linforth R. Radiological Staging of Symptomatic High Risk Breast Cancer Patients is of Limited Value. Euro J  Surg Onco,  39, 5, May 2013, 479


  • Thekkinkattil DK1, Salhab M, McManus PL. Feasibility of Autologous Fat Transfer for Replacement of Implant Volume in Complicated Implant-Assisted Latissimus Dorsi Flap Breast Reconstruction. Ann Plast Surg. 2013 Oct 21. [Epub ahead of print]


  • Salhab M, Patani N, Mokbel K. Sentinel Lymph Node Micrometastasis In Human Breast Cancer. An Update. Surg Oncol. 2011 Dec;20(4):e195-206.


  • Adams ST, Salhab M, Hussain ZI, Miller GV, Leveson SH. Roux-en-Y gastric bypass for morbid obesity: what are the preoperative predictors of weight loss? Postgrad Med J. 2013 Mar 7. [Epub ahead of print]


  • Adams S, Salhab M, Hussain Z, Miller G, Leveson S. Preoperatively determinable factors predictive of diabetes mellitus remission following Roux-en-Y gastric bypass: a review of literature. Acta Diabetol. 2013 Mar 7. [Epub ahead of print]


  • Adams ST, Salhab M, Hussain ZI, Miller GV, Leveson SH. Obesity-related hypertension and its remission following gastric bypass surgery - A review of the mechanisms and predictive factors. Blood Press. 2012 Dec 18. [Epub ahead of print]


  • Salhab M, Malik S, Aldoori M, Mahomed A. Arterial complications following knee arthroplasty Am J Case Rep 2010; 11. 263-266


  • Salhab M, Bismohun S, Mokbel K.  Risk-reducing strategies for women carrying BRCA1/2 mutations with a focus on prophylactic surgery. BMC Women's Health 2010, 10:28


  • Abbas K, Vohra RS, Salhab M, Sinclair MD, Kent PJ, Gough MJ. Carotid endarterectomy in symptomatic patients: A strategy to meet the ‘two week’ target. Clin Med. 2011 Oct;11(5):452-5


  • Salhab M, Patani N, Jiang W, Mokbel K. High TIMM17A Expression is Associated with Adverse Pathological & Clinical Outcomes in Human Breast Cancer. Breast Cancer. 2010 Oct 23. [Epub ahead of print]


  • Kulendran M, Salhab M, Mokbel K Oestrogen-synthesising enzymes and breast cancer.  Anticancer Res. 2009 Apr; 29(4):1095-109.


  • Salhab M, Singh-Ranger G, Mokbel R, Jouhra F, Jiang WG, Mokbel K. Cyclooxygenase-2 mRNA expression correlates with aromatase expression in human breast cancer. Journal of  Surgical Oncology. 2007 Oct 1; 96(5):424-8.


  • Salhab M, Reed M, Al Sarakbi W, Jiang WG, Mokbel K. The role of aromatase and 17-beta-hydroxysteroid dehydrogenase type 1 mRNA expression in predicting the clinical outcome in human breast cancer. Breast Cancer Res Treat. 2006 Sep; 99(2):155-62


  • Salhab M, Jiang WG, Newbold RF, Mokbel K. The expression of gene transcripts of telomere-associated genes in human breast cancer: correlation with clinico-pathological parameters and clinical outcome. Breast Cancer Res Treat 2008 May; 109(1):35-46.


  • Subramanian A, Salhab M, Mokbel K. Oestrogen producing enzymes and mammary carcinogenesis: a review. Breast Cancer Res Treat. 2008 Sep; 111(2):191-202.


  • Singh-Ranger G, Salhab M, Mokbel K. The role of cyclooxygenase-2 in breast cancer: Review. Breast Cancer Res Treat 2008 May; 109(2):189-98.


  • Salhab M, Sarakbi W, Joseph A, Sheards S, Travers J,. Mokbel K. Skin sparing mastectomy and immediate breast reconstruction, patients’ satisfaction and clinical outcome. Int J Clin Oncol. 2006 Feb; 11(1):51-4.


  • Salhab M, Keith L G, Laguens M, Reeves  W, Mokbel K.  The potential role dynamic thermal analysis in breast cancer detection.  Int Semin Surg Oncol 2006, 3, 3:8


  • Salhab M, Mokbel K. Breast cancer risk in flight attendants: An update. Int J Fertil Women’s Med. 2006 Sep-Oct;51(5):205-7

 

  • Salhab M, Al Sarakbi W, Mokbel K. Breast weight and hormone receptor status in women with breast cancer. Int Semin Surg Oncol .2005 May 16; 2(1):11.


  • Salhab M, Al Sarakbi W, Mokbel K. The evolving role of the dynamic thermal analysis in the early detection of breast cancer. Int Semin Surg Oncol. 2005 Apr 8; 2(1):8.


  • Salhab M, Al Sarakbi W, Perry N, Mokbel K.  Pneumothorax after a clinical breast fine-needle aspiration of a lump in a patient with Poland's syndrome. Int Semin Surg Oncol. 2005 Aug 19; 2:14.


  • Salhab M, Al Sarakbi W, Mokbel K. Skin and fat necrosis of the breast following methylene blue dye injection for sentinel node biopsy in a patient with breast cancer. Int Semin Surg Oncol. 2005; 28; 2(1):26.


  • Salhab M, Al Sarakbi W, Mokbel K. In Vitro Fertilization and breast cancer risk. A review. Int J Fertil Women’s Med. 2005 Nov-Dec; 50(6):259-66.


  • Salhab M, Farmer J, Osman I S. The impact of delay on survival in patients with ruptured abdominal aortic aneurysm. Vascular, 2006. 14(1): 38-42


  • Al Sarakbi W, Mokbel R, Salhab M, Jiang WG, Reed MJ, Mokbel K The role of STS and OATP-B mRNA expression in predicting the clinical outcome in human breast cancer. Anticancer Res 2006 Nov-Dec; 26(6C):4985-90.


  • Al Sarakbi W, Salhab M, Thomas V, Mokbel K. Is preoperative core biopsy accurate in determining the hormone receptor status in women with invasive breast cancer? Int Semin Surg Oncol. 2005 Aug 22; 2:15


  • Elkak A E, Meligonis G, Salhab M,  Mitchell B,  Blake JRS, Newbold RF, Mokbel K. hTERT protein expression is independent of clinicopathological parameters and c-Myc protein expression in human breast cancer. J Carcinog. 2005 Oct 4; 4:17.


  • Salhab M, Matai V, Salam M A. The Impact of functional endoscopic sinus surgery on the health status. Rhinology. 2004 Jun; 42(2):98-102.


  • Sarakbi W, Salhab M, Mokbel K. Do dairy products increase breast cancer risk? A review. Int J Fertil Women’s Med Int J Fertil, 2005 Nov-Dec; 50(6):244-9


  • Salam MA, Matai V, Salhab M, Hilger AW. The facial skin lesions "see and treat" clinic: a prospective study. Eur Arch Otorhinolaryngol. 2006 Aug;263(8):764-6


  • Hosseini-Asl S, Modarressi M, Atri M, Salhab M, Mokbel K, Mehdipour P. The Association between Telomerase Activity and The Expression of its RNA Component (hTR) in Breast Cancer: The Importance of DNase Treatment.  J Carcinog, 2006 5:17


  • Al Sarakbi W, Salhab M, Mokbel K. Does mammary ductoscopy have a role in clinical practice? Int Semin Surg Oncol.2006 Jun 30; 3(1):16.


  • Hosseini-Asl S, Atri M, Modarressi M  H, Salhab M, Mokbel K, Mehdipour P The expression of hTR and hTERT in human breast cancer: correlation with clinico-pathological parameters. Int Semin Surg Oncol 2006, 3:20.


  • Mokbel K, Salhab M. Self-perceived stress and breast cancer risk. BMJ. Online rapid response. 


Book Chapter

Salhab M, Mokbel K. The role of aromatase and other oestrogen producing enzymes in mammary
carcinogenesis. Metastasis of Breast Cancer­, Springer Publishers ISBN: 978-1-4020-5866-0


Mr Salhab is an Oncoplastic Breast Surgeon working at Bradford Teaching Hospitals and the Yorkshire Clinic. He is  an Honorary Clinical Senior Lecturer at the University of Leeds. Mr Salhab graduated from medical school (MD) in 1996. Following his qualification he had basic and higher surgical training in the UK. He underwent extensive surgical training in Oncoplastic Breast Surgery in London, Yorkshire, Paris and Brussels. ​
In 2011 he was awarded the degree of Master of Surgery (MS) from University of London for his research in the field of breast cancer molecular biology. He has published widely in the field of breast cancer and presented his work at national and international meetings. He also obtained a Postgraduate Diploma in Oncoplastic Breast Surgery from the University of East Anglia after completing a two year course in Oncoplastic Breast Surgery. In 2013 he completed his accreditation and gained the Certificate of Completion of Training (CCT), following this he was appointed as a Consultant Oncoplastic Breast Surgeon at Bradford Teaching Hospitals NHS Foundation Trust.
Mr Salhab is a fellow of the  Royal College of Surgeons of England  and a member of the Association of Breast Surgery and the ​European Society of Surgical Oncology.

Mo Salhab MD, MRCS, MS, PG Dip, FRCS

Oncoplastic, Reconstructive & Aesthetic Breast Surgeon 

follow me on facebook

Clinical Interests


Mr Salhab specialises in the diagnosis and management of diseases of the breast, including:


  • Benign breast disease, breast pain, nipple discharge and breast  infections.  


  • Family history, Breast cancer risk evaluation and genetic breast disease. 


  • Breast Cancer screening diagnosis and management and  sentinel node biopsy


  • Immediate and delayed breast reconstruction and nipple reconstruction.


  • Cosmetic breast surgery (augmentation, reduction and uplift)


  • Correction of breast abnormalities, nipple inversion and tuberous breasts


  • Correction of breast deformities by fat transfer and lipofilling


  • Male breast problems and gynaecomastia.